Planet Labs director sells 20,000 shares

Planet Labs PBC director Vijaya Gadde reported a sale of company stock.

Rhea-AI Filing Summary

Planet Labs PBC director Vijaya Gadde reported a sale of company stock. On January 22, 2026, Gadde sold 20,000 shares of Class A Common Stock of Planet Labs PBC at a weighted average price of $26.7675 per share, with individual trades occurring between $26.76 and $26.815.

After this transaction, Gadde beneficially owned 250,169 shares of Planet Labs PBC common stock in direct form. The filing notes that detailed trade-by-trade pricing within the reported range is available to regulators upon request.

Insider Trade Summary

Net Seller: 20,000 shares

Net Sell 1 txn

Insider Gadde Vijaya

Role Director

Sold 20,000 shs ($535K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	20,000	$26.7675	$535K

Holdings After Transaction: Class A Common Stock — 250,169 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.76 to $26.815, inclusive. The reporting person undertakes to provide the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Planet Labs (PL) disclose for Vijaya Gadde?

The company disclosed that director Vijaya Gadde sold 20,000 shares of Planet Labs PBC Class A Common Stock on January 22, 2026, in an open-market transaction reported on Form 4.

At what price did Vijaya Gadde sell Planet Labs (PL) shares on January 22, 2026?

The shares were sold at a weighted average price of $26.7675 per share, with individual trades executed at prices ranging from $26.76 to $26.815, inclusive.

How many Planet Labs (PL) shares does Vijaya Gadde own after the reported sale?

Following the sale, Vijaya Gadde beneficially owned 250,169 shares of Planet Labs PBC Class A Common Stock, held directly.

What is Vijaya Gadde’s relationship to Planet Labs PBC (PL)?

Vijaya Gadde is listed in the filing as a director of Planet Labs PBC. The Form 4 does not indicate officer status or 10% ownership.

Does the Planet Labs (PL) Form 4 explain how the sale prices were calculated?

Yes. The filing states that the reported price is a weighted average for multiple trades between $26.76 and $26.815, and that detailed trade-level pricing can be provided to the SEC staff upon request.

Were any derivative securities reported for Vijaya Gadde in this Planet Labs (PL) Form 4?

No derivative securities transactions were reported. The Form 4 only shows a transaction in non-derivative Class A Common Stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/23/2026 - 06:29 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gadde Vijaya

(Last) (First) (Middle)

C/O PLANET LABS PBC

645 HARRISON STREET

(Street)

SAN FRANCISCO CA 94107

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Planet Labs PBC [ PL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	01/22/2026		S		20,000	D	$26.7675(1)	250,169	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.76 to $26.815, inclusive. The reporting person undertakes to provide the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

	By: /s/ LeeAnn Linck, Attorney-in-fact for: Vijaya Gadde	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.